Health system delay in treatment of multidrug-resistant tuberculosis patients in Bangladesh
Citation: Rifat, M., Hall, J., Oldmeadow, C. et al. Health system delay in treatment of multidrug resistant tuberculosis patients in Bangladesh. BMC Infect Dis 15, 526 (2015). https://doi.org/10.1186/s12879-015-1253-9
Abstract: Bangladesh is one of the 27 high burden countries for multidrug resistant tuberculosis listed by the World Health Organization. Delay in multidrug resistant tuberculosis treatment may allow progression of the disease and affect the attempts to curb transmission of drug resistant tuberculosis. The main objective of this study was to investigate the health system delay in multidrug resistant tuberculosis treatment in Bangladesh and to explore the factors related to the delay.
Author(s): BMC Infectious Diseases
Resource Type: Journal Articles